Cellcept Lyophilisate For Solution For Injection 500Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

CellCept: Lyophilisate for solution for injection (500mg)

Detailed Information
Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

MYCOPHENOLATE MOFETIL (mye koe FEN oh late MOE fe til) is used to decrease the immune system's response to a transplanted organ.

In-Depth Information

CellCept 500mg Powder for Injection

NDC: 000040298
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Heart Transplant Rejection Prophylaxis, Liver Transplant Rejection Prophylaxis, Kidney Transplant Rejection Prophylaxis

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
CellCept 500mg Powder for Injection
Close All Sections Show

Reported Side Effects for CellCept 500mg Powder for Injection

Close Show
Secondary Malignancy Incidence:
0.4-4.2%*
Severity: MODERATE
Onset: DELAYED
Yeast Infection Incidence:
0.6-22.4%*
Severity: MODERATE
Onset: DELAYED
Infection Incidence:
0.6-37.2%*
Severity: MILD
Onset: DELAYED
Intestinal Bleeding Incidence:
1.0-5.4%*
Severity: SEVERE
Onset: DELAYED
Pancytopenia Incidence:
1.8-19.9%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cells Incidence:
2.0-3.6%*
Severity: MODERATE
Onset: DELAYED
Collapsed Lung Incidence:
3.0-19.9%*
Severity: SEVERE
Onset: EARLY
High Red Blood Cells Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Psychosis Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: EARLY
Convulsions Incidence:
3.0-19.9%*
Severity: SEVERE
Onset: DELAYED
Fainting Incidence:
3.0-19.9%*
Severity: MILD
Onset: EARLY
Testicular Swelling Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: EARLY
Rapid Heart Rate Incidence:
3.0-22.0%*
Severity: MODERATE
Onset: EARLY
Decreased Breathing Incidence:
3.0-19.9%*
Severity: SEVERE
Onset: DELAYED
Abnormal Heart Rhythm Incidence:
3.0-19.9%*
Severity: SEVERE
Onset: EARLY
Back Pain Incidence:
3.0-46.6%*
Severity: MILD
Onset: DELAYED
Skin Ulcer Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Blistery Rash Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: EARLY
Chest Pain Incidence:
3.0-26.3%*
Severity: MODERATE
Onset: EARLY
Chills Incidence:
3.0-19.9%*
Severity: MILD
Onset: RAPID
Confusion Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: EARLY
Cholestasis Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Coagulopathy Incidence:
3.0-19.9%*
Severity: SEVERE
Onset: DELAYED
Difficulty Swallowing Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Weight Loss Incidence:
3.0-19.9%*
Severity: MILD
Onset: DELAYED
Blood In The Urine Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Liver Infection Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Sugar Incidence:
3.0-46.7%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Fats Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Volume Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Weight Gain Incidence:
3.0-19.9%*
Severity: MILD
Onset: DELAYED
Visual Impairment Incidence:
3.0-19.9%*
Severity: SEVERE
Onset: EARLY
Flu Incidence:
3.0-19.9%*
Severity: MILD
Onset: DELAYED
Yellow Skin Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Vesicular Rash Incidence:
3.0-19.9%*
Severity: MILD
Onset: DELAYED
Low White Blood Cell Counts Incidence:
3.0-45.8%*
Severity: MODERATE
Onset: DELAYED
Muscle Cramps Incidence:
3.0-19.9%*
Severity: MILD
Onset: DELAYED
Throat Irritation Incidence:
3.0-19.9%*
Severity: MILD
Onset: EARLY
Nerve Pain Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Rapid Heart Rate Incidence:
3.0-22.0%*
Severity: MODERATE
Onset: RAPID
Cyst Of Lymph Fluid Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Feeling Sick Incidence:
3.0-19.9%*
Severity: MILD
Onset: EARLY
Melena Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Muscle Weakness Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Nighttime Urination Incidence:
3.0-19.9%*
Severity: MILD
Onset: EARLY
Bleeding Within The Eye Incidence:
3.0-19.9%*
Severity: SEVERE
Onset: DELAYED
Mouth Sores Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Ear Pain Incidence:
3.0-19.9%*
Severity: MILD
Onset: EARLY
Pale Skin Incidence:
3.0-19.9%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: EARLY
Pelvic Pain Incidence:
3.0-19.9%*
Severity: MILD
Onset: DELAYED
Rhinitis Incidence:
3.0-19.9%*
Severity: MILD
Onset: EARLY
Peripheral Vasodilation Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: RAPID
Kidney Damage Incidence:
3.0-19.9%*
Severity: SEVERE
Onset: DELAYED
Red Spotted Rash Incidence:
3.0-19.9%*
Severity: MILD
Onset: DELAYED
Excessive Thirst Incidence:
3.0-19.9%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
3.0-22.1%*
Severity: MILD
Onset: EARLY
Kidney Failure Incidence:
3.0-19.9%*
Severity: SEVERE
Onset: DELAYED
Conjunctivitis Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
3.0-28.7%*
Severity: MILD
Onset: EARLY
Hoarseness Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Bruise Incidence:
3.0-19.9%*
Severity: MILD
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
3.0-24.9%*
Severity: MODERATE
Onset: DELAYED
Emotional Lability Incidence:
3.0-19.9%*
Severity: MILD
Onset: EARLY
Heartburn Incidence:
3.0-19.9%*
Severity: MILD
Onset: DELAYED
Gingival Hyperplasia Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Hallucinations Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: EARLY
Deafness Incidence:
3.0-19.9%*
Severity: SEVERE
Onset: DELAYED
Coughing Up Blood Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Hiccups Incidence:
3.0-19.9%*
Severity: MILD
Onset: EARLY
Excessive Mucle Tone Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Overbreathing Incidence:
3.0-19.9%*
Severity: MILD
Onset: EARLY
Hypoxia Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: EARLY
Decreased Healing Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Impotence (erectile Dysfunction) Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Increased Urination Incidence:
3.0-19.9%*
Severity: MILD
Onset: EARLY
Secretion Of Tears Incidence:
3.0-19.9%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
3.0-36.7%*
Severity: MODERATE
Onset: EARLY
Painful Urination Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: EARLY
Swelling Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Nose Bleed Incidence:
3.0-19.9%*
Severity: MILD
Onset: DELAYED
Throat Inflammation Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Tired Incidence:
3.0-19.9%*
Severity: MILD
Onset: EARLY
Gas Incidence:
3.0-19.9%*
Severity: MILD
Onset: EARLY
Inflamed Stomach Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Gum Inflammation Incidence:
3.0-19.9%*
Severity: MILD
Onset: DELAYED
Gout Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Heart Failure Incidence:
3.0-19.9%*
Severity: SEVERE
Onset: DELAYED
Hirsutism Incidence:
3.0-19.9%*
Severity: MILD
Onset: DELAYED
High Bilirubin Level Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
High Calcium Levels Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
High Cholesterol Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
High Potassium Level Incidence:
3.0-22.0%*
Severity: SEVERE
Onset: DELAYED
High Phosphate Levels Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
High Blood Pressure Incidence:
3.0-77.5%*
Severity: MODERATE
Onset: EARLY
High Uric Acid Level Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Low Calcium Levels Incidence:
3.0-30.0%*
Severity: MODERATE
Onset: DELAYED
Acne Incidence:
3.0-19.9%*
Severity: MILD
Onset: DELAYED
Distressed Incidence:
3.0-19.9%*
Severity: MILD
Onset: EARLY
Hair Loss Incidence:
3.0-19.9%*
Severity: MILD
Onset: DELAYED
Lazy Eye Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Anemia Incidence:
3.0-43.0%*
Severity: MODERATE
Onset: DELAYED
Chest Pain Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: EARLY
Nervousness Incidence:
3.0-28.4%*
Severity: MILD
Onset: DELAYED
Joint Pain Incidence:
3.0-19.9%*
Severity: MILD
Onset: DELAYED
Irregular Heart Beat Incidence:
3.0-19.9%*
Severity: SEVERE
Onset: EARLY
Irregular Heart Rate Incidence:
3.0-19.9%*
Severity: SEVERE
Onset: EARLY
Bladder Spasm Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: EARLY
Slow Heart Beat Incidence:
3.0-19.9%*
Severity: SEVERE
Onset: RAPID
Suddenly Stopped Heart Incidence:
3.0-19.9%*
Severity: SEVERE
Onset: EARLY
Cholangitis Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Cough Incidence:
3.0-31.1%*
Severity: MILD
Onset: DELAYED
Cushing's Syndrome Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Dehydration Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Delirium Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: EARLY
Depression Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Diabetes Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Drowsiness Incidence:
3.0-19.9%*
Severity: MILD
Onset: EARLY
Decreased Urination Incidence:
3.0-19.9%*
Severity: SEVERE
Onset: EARLY
Postural Low Blood Pressure Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Osteoporosis Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Fluid Around The Heart Incidence:
3.0-19.9%*
Severity: SEVERE
Onset: DELAYED
Sore Throat Incidence:
3.0-19.9%*
Severity: MILD
Onset: DELAYED
Fluid Around The Lungs Incidence:
3.0-34.3%*
Severity: SEVERE
Onset: DELAYED
Itching Incidence:
3.0-19.9%*
Severity: MILD
Onset: RAPID
Fluid In Lungs Incidence:
3.0-19.9%*
Severity: SEVERE
Onset: EARLY
High Pressure In Lungs Incidence:
3.0-19.9%*
Severity: SEVERE
Onset: DELAYED
Sinus Infection Incidence:
3.0-26.0%*
Severity: MILD
Onset: DELAYED
Mouth Ulcers Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Low Platelet Count Incidence:
3.0-38.3%*
Severity: MODERATE
Onset: DELAYED
Ringing In Ears Incidence:
3.0-19.9%*
Severity: MILD
Onset: DELAYED
Shaking Incidence:
3.0-33.9%*
Severity: MILD
Onset: EARLY
Uncontrolled Urination Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: EARLY
Retaining Urine Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: EARLY
Rapid Heart Rate Incidence:
3.0-22.0%*
Severity: SEVERE
Onset: EARLY
Balance Problems Incidence:
3.0-19.9%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
3.0-19.9%*
Severity: MILD
Onset: EARLY
Cataracts Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Low Chloride Levels Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Low Blood Sugar Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: EARLY
Low Potassium Levels Incidence:
3.0-37.2%*
Severity: MODERATE
Onset: DELAYED
Low Magnesium Levels Incidence:
3.0-39.0%*
Severity: MODERATE
Onset: DELAYED
Low Blood Sodium Levels Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Low Phosphate Level Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Low Blood Pressure Incidence:
3.0-32.5%*
Severity: MODERATE
Onset: RAPID
Underactive Thyroid Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Low Blood Volume Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: EARLY
Bowel Obstruction Incidence:
3.0-19.9%*
Severity: SEVERE
Onset: DELAYED
Stuffy Nose Incidence:
3.0-19.9%*
Severity: MILD
Onset: EARLY
Muscle Pain Incidence:
3.0-19.9%*
Severity: MILD
Onset: EARLY
Electrolyte Imbalance Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Electrolyte Imbalance Incidence:
3.0-19.9%*
Severity: MODERATE
Onset: DELAYED
Irritated Blood Vessels Incidence:
4.0%*
Severity: MODERATE
Onset: RAPID
Blood Clot Incidence:
4.0%*
Severity: SEVERE
Onset: DELAYED
Headache Incidence:
16.1-54.3%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
18.5-41.2%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
19.0-54.5%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
19.0-22.5%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
20.0-33.9%*
Severity: MILD
Onset: EARLY
Paresthesias Incidence:
20.8%*
Severity: MILD
Onset: DELAYED
Loose Stools Incidence:
21.4-51.3%*
Severity: MILD
Onset: EARLY
Fever Incidence:
21.4-52.3%*
Severity: MILD
Onset: EARLY
Birth Defect Incidence:
22.0%*
Severity: SEVERE
Onset: DELAYED
High White Blood Cells Incidence:
22.4-40.5%*
Severity: MILD
Onset: DELAYED
Inability To Sleep Incidence:
23.5-52.3%*
Severity: MILD
Onset: EARLY
Extra Abdominal Fluid Incidence:
24.2%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
24.7-62.5%*
Severity: MILD
Onset: EARLY
Decreased Appetite Incidence:
25.3%*
Severity: MILD
Onset: DELAYED
Fluid Retention Incidence:
27.0-64.0%*
Severity: MODERATE
Onset: DELAYED
Low Kidney Function Incidence:
34.6%*
Severity: SEVERE
Onset: DELAYED
Weakness Incidence:
35.4-43.3%*
Severity: MILD
Onset: DELAYED
Aborted Pregnancy Incidence:
45.0%*
Severity: SEVERE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
Close Show
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with CellCept

Close Show

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5